
Schibsted invests in Norwegian health-tech startup, Askin
Askin offers consultation and e-prescriptions through an in-house developed platform is currently experiencing an increasing interest in its services.
We’re growing, changing, and making things better every day. This is your place to follow our journey — through stories, insights and news from across the company.
Showing 91-100 of 127 results
Askin offers consultation and e-prescriptions through an in-house developed platform is currently experiencing an increasing interest in its services.
It's that time of the year. Our annual outlook on key trends within tech, people and business, written by our own employees, is finally here.
FAST is a new Schibsted-wide framework for risk analysis in AI. The framework provides a common basis for approaching risks in the areas of Fairness, Accountability, Sustainability and Transparency, and it is currently being piloted across our group.
Acquires Strawberry’s shares
Tibber’s acquisition of Kundkraft makes Schibsted a shareholder in Tibber.
With more than 12 years of experience building diversity in society, Sumeet Singh Patpatia will be responsible for ensuring that Schibsted has the right practices in place to attract and retain a workforce that is as diverse as our customers.
SYD offers organic period products on subscription.
A day we've been looking forward to since last summer.
Today, Schibsted has launched the yearly Second Hand Effect report together with Adevinta.
The UK Competition and Markets Authority accepts remedies in principle